tirzepatide vs semaglutide vs retatrutide for weight loss: Study shows 30% body weight loss Retatrutide vs Tirzepatide: a Quick

L.WangY.et al

The peptide activates AMP-activated protein kinase (AMPK), a central regulator of cellular energy metabolism that promotes fatty acid oxidation while inhibiting lipid synthesis

It works as a gentle continuation or maintenance course, helping to stabilize blood sugar, support fat burning, and maintain satiety

And when it stops, it is very serious

Diabetes 37 , 172176 (1988)

European Union Requires NAION Warnings for Semaglutide In June 2025, the European Medicines Agency (EMA) required semaglutide products Ozempic, Wegovy and Rybelsus to include a warning that the medications may cause a very rare increased risk of NAION